← FDA Drug Approvals (Drugs@FDA)

ESCITALOPRAM OXALATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2025-07-15

Drug application

FDA Application #

ANDA215177

Application type

Abbreviated New Drug Application (Generic)

Brand name

ESCITALOPRAM OXALATE

Generic name

ESCITALOPRAM

Active ingredients

ESCITALOPRAM OXALATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ASCENT PHARMS INC

Manufacturer

Ascent Pharmaceuticals, Inc

First approval

2025-07-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown